1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow VX-561: new trials by email Literature Review of VX-561 trials Research Report on VX-561
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Safety and Efficacy of CTP-656 in Patients With Cystic Fibrosis With CFTR Gating Mutations VX-561, Placebo, IVA - Cystic Fibrosis | Phase 2 | Terminated | Vertex Pharmaceuticals Incorporated | 11 | 2016-12-01 | 2020-08-26 |
Cystic Fibrosis (1)
Vertex Pharmaceuticals Incorporated (1)
United States (1)